CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • December 22nd, 2022 • Johnson & Johnson • Pharmaceutical preparations • Delaware
THIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of December 22, 2022 (this “Agreement”), is entered into by and between Johnson & Johnson, a New Jersey corporation (“Parent”), and American Stock Transfer & Trust Company, LLC, a New York limited liability trust company, as Rights Agent (the “Rights Agent”).
